JSLLPharmaceuticals
Jeena Sikho Lifecare Limited — PE Ratio & Valuation Analysis
₹539.70
-6.87%
Current P/E58.20xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E209.1x72.2% below avg
⚠️
83.2% Premium to Industry
JSLL P/E 58.20x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹7.30 | ₹681 | 93.2x |
| 2024 | ₹5.57 | ₹2130 | 382.6x |
| 2023 | ₹2.74 | ₹591 | 215.9x |
| 2022 | ₹0.90 | ₹131 | 144.7x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Jeena Sikho Lifecare Limited Valuation
Jeena Sikho Lifecare Limited (JSLL) currently trades at 58.20x earnings. The Pharmaceuticals sector average PE is 31.77x. JSLL commands a premium, reflecting high growth expectations. Historically, JSLL has traded at an average PE of 209.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
37.93%
Dividend Yield
0.15%
More on Jeena Sikho Lifecare Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.